Publications

2017

G Yebra, D Frampton, T Gallo Cassarino, J Raffle, J Hubb, B Ferns, Z Kozlakidis, A Hayward, P Kellam, D Pillay, D Clark, E NastouliAJ Leigh Brown. A High HIV-1 Strain Variability in London, UK, Revealed by Full-Genome Analysis: Results from the ICONIC Project. bioRxiv; doi: https://doi.org/10.1101/139642

2016

G Yebra, EB Hodcroft, M Ragonnet-Cronin, D Pillay, AJ Leigh Brown on behalf of the PANGEA_HIV Consortium & the ICONIC Project. Using nearly full-genome HIV sequence data improves phylogeny reconstruction in a simulated epidemic. Sci Rep 2016; 6:39489. Sci Rep

S Pérez-Parra, N Chueca, M Álvarez, J Pasquau, M Omar, A Collado, D Vinuesa, AB Lozano, Yebra, F García. Phylodynamic and phylogeographic profiles of subtype B HIV-1 epidemics in South Spain. PLoS ONE 2016; 11:e0168099. PLoS ONE

G Yebra, ML Kalish, AJ Leigh Brown. Reconstructing the HIV-1 CRF02_AG and CRF06_cpx epidemics in Burkina Faso and West Africa using early samples. Infect Genet Evol 2016; 46:209-18. PubMed

E Torrecilla, G Yebra, T Llácer-Delicado, R Rubio, J González-García, F García, J López-Aldeguer, V Asensi, Á Holguín. Clinical, epidemiological and treatment failure data among HIV-1 non-B-infected patients in the Spanish AIDS Research Network Cohort. Enferm Infecc Microbiol Clin 2016; 34:353-60. PubMed

2015

G Yebra, M Ragonnet-Cronin, D Ssemwanga, CM Parry, CH Logue, P Cane, P Kaleebu, AJ Leigh Brown. Analysis of the history and spread of HIV-1 in Uganda using phylodynamics. J Gen Virol 2015; 96: 1890-98. J Gen Virol

SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey [63 more authors], R Yang, G Yebra, JPA Ioannidis, AM Vandamme, RW Shafer. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis. PLoS Med 2015; 12: e1001810. PLoS Medicine

2014

G Yebra, R Delgado, F Pulido, R Rubio, S Moreno, Á Holguín. Different trends on the transmitted HIV-1 drug resistance in Madrid (Spain) among risk groups in the last decade. Arch Virol 2014; 159: 1079-87. PubMed

2013

Á Holguín, G Yebra, L Martín, AT de Pineda, LE Ruiz, AY Quezada, AI Nieto, G Escobar. Transmitted drug resistance in HIV-infected adult population in El Salvador, Central America. Clin Microbiol Infect 2013; 19: E523–E532. PubMed

G Yebra, M de Mulder, Á Holguín. Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain. PLoS ONE 2013; 8:e64293. PLoS ONE

G Yebra, Á Holguín, D Pillay, S Hué. Phylogenetic and demographic characterization of HIV-1 transmission in Madrid, Spain. Infect Genet Evol 2013; 14:232-9. PubMed

2012

M de Mulder, G Yebra, A Navas, MI de José, MD Gurbindo, MI González-Tomé, MJ Mellado, J Saavedra-Lozano, MÁ Muñoz-Fernández, SJ de Ory, JT Ramos, Á Holguín. High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain. PLoS ONE 2012; 7: e52155. PLoS ONE

M de Mulder, G Yebra, A Navas, L Martín, MI de José, ML Navarro, S Jiménez de Ory, I González-Granados, MJ Mellado, JT Ramos, Á Holguín. Trends in drug resistance prevalence in HIV-1 infected children: 1993-2010 analysis. Pediatr Infect Dis J 2012; 31:e213-21. PubMed

G Yebra, M de Mulder, L Martín, C Rodríguez, P Labarga, I Viviana, J Berenguer, MR Alemán, JA Pineda, F García, Á Holguín, on behalf of CoRIS. Most HIV-1 non-B infections in the Spanish cohort of antiretroviral treatment naïve HIV-infected patients (CoRIS) are due to recombinant viruses. J Clin Microbiol 2012; 50:407-13. PubMed

2011

G Yebra, M de Mulder, MJ Pérez-Elías, JA Pérez-Molina, JC Galán, J Llenas-García, S Moreno, Á Holguín. Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population. PLoS ONE 2011; 6: e26757. PLoS ONE

G Yebra, Á Holguín. Mutation Vif-22H, which allows HIV-1 to use the APOBEC3 hypermutation to develop resistance, could appear faster in certain non-B variants. J Antimicrob Chemother 2011; 66:941-2. PubMed

G Yebra, M de Mulder, L Martín, S Pérez-Cachafeiro, C Rodríguez, P Labarga, F García, C Tural, À Jaén, G Navarro, Á Holguín, on behalf of CoRIS. Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS). Antivir Res 2011; 89:19-25. PubMed

M de Mulder, G Yebra, L Martín, L Prieto, MJ Mellado, P Rojo, MA Muñoz-Fernández, S Jiménez de Ory, JT Ramos, Á Holguín. Drug resistance and HIV-1 variant characterization in naïve and pretreated HIV-1 infected pediatric population in Madrid. J Antimicrob Chemother 2011; 66:2362-71. PubMed

Á Holguín, K Erazo, G Escobar, M de Mulder, G Yebra, L Martín, LE Jovel, L Castaneda, E Pérez, on behalf of Proyecto Esther. Drug resistance prevalence and HIV-1 variant characterization in HIV-1 infected pediatric populations in Honduras and El Salvador during 1989-2009 period. Ped Infec Dis J 2011; 30:e82-e87. PubMed

2010

G Yebra, M de Mulder, J del Romero, C Rodríguez, Á Holguín. HIV-1 non-B subtypes: high transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability. Antivir Res 2010; 85:409-17. PubMed

G Yebra, Á Holguín. Epidemiology of drug-resistant HIV-1 transmission in naïve patients in Spain. Med Clin (Barc) 2010; 135:561-7. PubMed

2009

G Yebra, P Rivas, MD Herrero, M López, M de Mulder, S Puente, G Ramírez-Olivencia, V Soriano, Á Holguín. Clinical differences and viral diversity between newly HIV-diagnosed African and non-African patients in Spain (2005-2007). AIDS Res and Hum Retroviruses 2009; 25:37-44. PubMed

2008

G Yebra, Á Holguín. The maturation inhibitor bevirimat (PA-457) can be active in patients carrying HIV type-1 non-B subtypes and recombinants. Antivir Ther 2008; 13:1083-5. PubMed

Á Holguín, M de Mulder, G Yebra, M López, V Soriano. Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. Curr HIV Res 2008; 6:327-34. PubMed

Advertisements